Episode Summary
In this episode, John discusses our take on health care news in the last week of October. He covers President Trump’s proposed change on how Medicare pays for certain drugs, based on an international pricing index of drugs.
Episode Notes
Hoping all of our listeners had a wonderful and safe Halloween!
In this episode, John discusses our take on health care news in the last week of October. He covers President Trump’s proposed change on how Medicare pays for certain drugs, based on an international pricing index of drugs.
- HHS Secretary Alex Azar referenced a report his agency recently completed—which compared U.S. prices for 27 drugs with prices for the same drugs in 16 other countries—tweeting that “Among these drugs, on average, the US pays 180% more than the international price.” HHS said the rule would include most of the drugs in Medicare Part B, which covers injectables and many specialty medications.
About Darwin Research Group
Darwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin’s client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.
CONNECT WITH US:
🌐 Follow Health Care Rounds on LinkedIn
🌐 Follow Darwin Research Group on LinkedIn
📺 Watch Health Care Rounds on YouTube
⚙️ Health Care Rounds is produced by Grippi Media
Recommended Next
Subscribe to Our Take
Sign up for Our Take Newsletter: highly curated, expert weekly strategic insights for health care executives.
